Glial gene–protein networks in neuroinflammation and disease transitions
Neuroinflammatory responses emerge from interacting molecular configurations rather than from uniform activation programs. This review examines how extracellular cues, receptor and sensor systems, intracellular signaling pathways, gene and protein effectors, and reciprocal microglia–astrocyte communication combine to shape glial function across neurological disease. Particular attention is given to nuclear factor kappa B, Janus kinase/signal transducer and activator of transcription 3 (STAT3), transforming growth factor beta, interferon-associated signaling, purinergic receptors, inflammasome pathways, ion and water transport systems, complement, and extracellular matrix regulation. Mechanistic comparisons show that pathway identity alone does not determine biological output: receptor context, interacting molecular partners, glial cell type, signal duration, disease phase, and local tissue environment alter whether related regulatory modules support surveillance, clearance, repair-associated remodeling, persistent inflammation, or tumor-associated niche organization. These principles are compared across Alzheimer’s disease, Parkinson’s disease, stroke, and glioblastoma, revealing substantial differences in initiating signals, temporal organization, cellular interactions, and evidentiary strength. Transcriptomic, proteomic, cerebrospinal fluid, blood, and spatial profiling further demonstrate that measurable glial states require interpretation by biological source and validation level. Experimental interventions targeting NLR family pyrin domain-containing protein 3, astrocytic water-channel systems, microglial populations, STAT3-associated signaling, and glioblastoma microenvironmental interactions illustrate that therapeutic effects depend not only on the molecular target but also on the glial and disease configuration in which it operates. A configuration-based interpretation of glial gene–protein networks therefore provides a mechanistic basis for comparing disease states, evaluating biomarkers, and matching molecular interventions to biologically defined therapeutic windows.
- Chhatbar C, Sankowski R, Schulz M, et al. A transcriptomic microglia taxonomy across mouse and human pathologies. Nat Immunol. 2026;27(5):1066-1080. doi: 10.1038/s41590-026-02472-z
- Clayton BLL, Liddelow SA. Heterogeneity of Astrocyte Reactivity. Annu Rev Neurosci. 2025;48(1):231-249. doi: 10.1146/annurev-neuro-112723-031738
- Depp C, Doman JL, Hingerl M, Xia J, Stevens B. Microglia transcriptional states and their functional significance: Context drives diversity. Immunity. 2025;58(5):1052-1067. doi: 10.1016/j.immuni.2025.04.009
- Gabitto MI, Travaglini KJ, Rachleff VM, et al. Integrated multimodal cell atlas of Alzheimer’s disease. Nat Neurosci. 2024;27(12):2366-2383. doi: 10.1038/s41593-024-01774-5
- Martins-Ferreira R, Calafell-Segura J, Leal B, et al. The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nat Commun. 2025;16(1):739. doi: 10.1038/s41467-025-56124-1
- Faust TE, Lee YH, O’Connor CD, et al. Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling. Cell. 2025;188(19):5212-5230.e21. doi: 10.1016/j.cell.2025.08.023
- Ferrari-Souza JP, Povala G, Rahmouni N, et al. Microglia modulate Abeta-dependent astrocyte reactivity in Alzheimer’s disease. Nat Neurosci. 2026;29(1):81-87. doi: 10.1038/s41593-025-02103-0
- Garcia-Dominguez M. Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications. Biomedicines. 2026;14(1):115. doi: 10.3390/biomedicines14010115
- Shang T, Kuang B, Shang Y, Zou W. Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies. Curr Neuropharmacol. 2025;23(13):1645-1665. doi: 10.2174/011570159X350639250403072430
- Muller L, Di Benedetto S, Muller V. The dual nature of neuroinflammation in networked brain. Front Immunol. 2025;16:1659947. doi: 10.3389/fimmu.2025.1659947
- Miller TE, El Farran CA, Couturier CP, et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature. 2025;640(8060):1072-1082. doi: 10.1038/s41586-025-08633-8
- Read RD, Tapp ZM, Rajappa P, Hambardzumyan D. Glioblastoma microenvironment-from biology to therapy. Genes Dev. 2024;38(9-10):360-379. doi: 10.1101/gad.351427.123
- Scott EY, Safarian N, Casasbuenas DL, et al. Integrating single-cell and spatially resolved transcriptomic strategies to survey the astrocyte response to stroke in male mice. Nat Commun. 2024;15(1):1584. doi: 10.1038/s41467-024-45821-y
- Sonpatki P, Park HJ, Xing YL, et al. A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of anatomical niches. Nat Commun. 2026;17(1):2951. doi: 10.1038/s41467-026-69716-2
- Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267. doi: 10.1038/s41392-023-01486-5
- Chang NP, DaPrano EM, Lindman M, et al. Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling. JCI Insight. 2024;9(11):e177002. doi: 10.1172/jci.insight.177002
- Xu W, Huang Y, Zhou R. NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. 2025;22(4):341-355. doi: 10.1038/s41423-025-01275-w
- Lee SY, Chung WS. Astrocytic crosstalk with brain and immune cells in healthy and diseased conditions. Curr Opin Neurobiol. 2024;84:102840. doi: 10.1016/j.conb.2024.102840
- Zhao Y, Huang Y, Cao Y, Yang J. Astrocyte-Mediated Neuroinflammation in Neurological Conditions. Biomolecules. 2024;14(10):1204. doi: 10.3390/biom14101204
- Peggion C, Cali T, Brini M. Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First? Antioxidants. 2024;13(2):240. doi: 10.3390/antiox13020240
- Peruzzotti-Jametti L, Willis CM, Krzak G, et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature. 2024;628(8006):195-203. doi: 10.1038/s41586-024-07167-9
- Qin P, Sun Y, Li L. Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review). Int J Mol Med. 2024;53(5):47. doi: 10.3892/ijmm.2024.5371
- Lei W, Zhuang H, Huang W, Sun J. Neuroinflammation and energy metabolism: a dual perspective on ischemic stroke. J Transl Med. 2025;23(1):413. doi: 10.1186/s12967-025-06440-3
- Han J, Zhang Z, Zhang P, et al. The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease. Front Neurosci. 2025;19:1575453. doi: 10.3389/fnins.2025.1575453
- Guan X, Zhu S, Song J, et al. Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke. Cell Rep Med. 2024;5(5):101522. doi: 10.1016/j.xcrm.2024.101522
- Yang S, Chen Y, Tang J, et al. Microglia-astrocyte crosstalk following ischemic stroke. Mol Brain. 2025;18(1):75. doi: 10.1186/s13041-025-01244-4
- Dai J, Jiang Y, Hu H, Zhang S, Chen Y. Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment. Pathol Oncol Res. 2024;30:1611549. doi: 10.3389/pore.2024.1611549
- Schweiger MW, Amoozgar Z, Repiton P, et al. Glioblastoma extracellular vesicles modulate immune PD-L1 expression in accessory macrophages upon radiotherapy. iScience. 2024;27(2):108807. doi: 10.1016/j.isci.2024.108807
- Wang B, Li C, Gu J, et al. Targeting glioma-associated microglia and macrophages: a new frontier in glioblastoma immunotherapy. Front Immunol. 2025;16:1726440. doi: 10.3389/fimmu.2025.1726440
- Hein TM, Nespoli E, Hakani M, et al. NF-kappaB activation in astrocytes impairs wound healing after traumatic brain injury in male mice. Nat Commun. 2026;17(1):2323. doi: 10.1038/s41467-026-70304-7
- Anilkumar S, Wright-Jin E. NF-kappaB as an Inducible Regulator of Inflammation in the Central Nervous System. Cells. 2024;13(6):485. doi: 10.3390/cells13060485
- Spielbauer J, Glotfelty EJ, Sarlus H, Harris RA, Diaz Heijtz R, Karlsson TE. Bacterial peptidoglycan signalling in microglia: Activation by MDP via the NF-kappaB/MAPK pathway. Brain Behav Immun. 2024;121:43-55. doi: 10.1016/j.bbi.2024.06.027
- Hay AJD, Popichak KA, Mumford G, et al. Microglia-specific NF-kappaB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss. PLoS Pathog. 2025;21(6):e1012582. doi: 10.1371/journal.ppat.1012582
- Ageeva T, Rizvanov A, Mukhamedshina Y. NF-kappaB and JAK/STAT Signaling Pathways as Crucial Regulators of Neuroinflammation and Astrocyte Modulation in Spinal Cord Injury. Cells. 2024;13(7):581. doi: 10.3390/cells13070581
- Li Y, Xie Y, Liu R, et al. Regulatory T cells attenuate astrogliosis via IL-10/STAT3/PKC/vimentin signaling and promote neurological recovery after spinal cord injury. Neurotherapeutics. 2026;23(1):e00827. doi: 10.1016/j.neurot.2025.e00827
- Wu T, Ma Y, Yang Y, et al. Photobiomodulation reduces spinal cord edema by decreasing the expression of AQP4 in the astrocytes of male spinal cord injury rats via the JAK2/STAT3 signaling pathway. Photodiagnosis Photodyn Ther. 2024;50:104364. doi: 10.1016/j.pdpdt.2024.104364
- Reyes C, Mokalled MH. Astrocyte-Neuron Interactions in Spinal Cord Injury. Adv Neurobiol. 2024;39:213-231. doi: 10.1007/978-3-031-64839-7_9
- Yang G, Xu X, Gao W, Wang X, Zhao Y, Xu Y. Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration. Front Cell Neurosci. 2025;19:1700692. doi: 10.3389/fncel.2025.1700692
- Golan-Cancela I, Caja L. The TGF-beta Family in Glioblastoma. Int J Mol Sci. 2024;25(2):1067. doi: 10.3390/ijms25021067
- Vidovic N, Spittau B. Microglial Transforming Growth Factor-beta Signaling in Alzheimer’s Disease. Int J Mol Sci. 2024;25(6):3090. doi: 10.3390/ijms25063090
- Kimura K, Subramanian A, Yin Z, et al. Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease. Nature. 2025;641(8063):718-731. doi: 10.1038/s41586-025-08852-z
- Gulen MF, Samson N, Keller A, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620(7973):374-380. doi: 10.1038/s41586-023-06373-1
- Lopez-Atalaya JP, Bhojwani-Cabrera AM. Type I interferon signalling and interferon-responsive microglia in health and disease. FEBS J. 2025;292(22):5921-5940. doi: 10.1111/febs.70126
- Singhal G, Singhal S, Baune BT. Role of astrocyte in neuroinflammation-induced loss in neuroplasticity and subsequent onset of depression: A systematic review. Neuroprotection. 2025;3(3):206-225. doi: 10.1002/nep3.70009
- Tsaktanis T, Beyer T, Nirschl L, et al. Interferon-beta and FTY720 ameliorate progressive CNS inflammation via SOCS1-associated astrocyte signaling. Sci Rep. 2026;16(1):9851. doi: 10.1038/s41598-026-45303-9
- Naffaa MM. Mechanisms of astrocytic and microglial purinergic signaling in homeostatic regulation and implications for neurological disease. Explor Neurosci. 2025;4:100676. doi: 10.37349/en.2025.100676
- Fu J, Wang R, He J, et al. Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease. Front Immunol. 2025;16:1508023. doi: 10.3389/fimmu.2025.1508023
- McKenzie A, Dombrower R, Theeraphapphong N, McKenzie S, Hijazin MA. Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies. Biomedicines. 2025;14(1):58. doi: 10.3390/biomedicines14010058
- Makarava N, Safadi T, Bocharova O, et al. Knockout of P2Y12 receptor facilitates microglia-neuron body-to-body interactions and accelerates prion disease. bioRxiv. Preprint posted online 2025. doi: 10.1101/2025.04.07.647619
- Stoessel MB, Stowell RD, Lowery RL, et al. The effects of P2Y12 loss on microglial gene expression, dynamics, and injury response in the cerebellum and cerebral cortex. Brain Behav Immun. 2025;128:99-120. doi: 10.1016/j.bbi.2025.03.036
- Bedetta M, Pizzo P, Lia A. The Multifaceted Role of P2X7R in Microglia and Astrocytes. Neurochem Res. 2025;50(4):239. doi: 10.1007/s11064-025-04502-y
- Rifat A, Ossola B, Burli RW, et al. Differential contribution of THIK-1 K(+) channels and P2X7 receptors to ATP-mediated neuroinflammation by human microglia. J Neuroinflammation. 2024;21(1):58. doi: 10.1186/s12974-024-03042-6
- Zhang K, Ran R, Zhang CJ, Wang L, Zhang HH. Focus on P2X7R in microglia: its mechanism of action and therapeutic prospects in various neuropathic pain models. Front Pharmacol. 2025;16:1555732. doi: 10.3389/fphar.2025.1555732
- Ciani M, Rigillo G, Bertarini B, Benatti C, Alboni S, Tascedda F. Neuroimmune modulatory effects of the NLRP3 inflammasome: the role of sex and living environment in brain affecting conditions. Front Immunol. 2025;16:1711656. doi: 10.3389/fimmu.2025.1711656
- Zhang L, Tang Y, Huang P, et al. Role of NLRP3 inflammasome in central nervous system diseases. Cell Biosci. 2024;14(1):75. doi: 10.1186/s13578-024-01256-y
- Auger A, Faidi R, Rickman AD, et al. Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration. npj Dement. 2025;1(1):3. doi: 10.1038/s44400-025-00011-5
- Hashimoto K, Gotoh M, Ikeshima-Kataoka H. Astrocytic and microglial cell functions in neuroinflammatory diseases and their animal models. Front Cell Neurosci. 2025;19:1708775. doi: 10.3389/fncel.2025.1708775
- Tripathy DK, Panda LP, Biswal S, Barhwal K. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol. 2024;15:1355242. doi: 10.3389/fphar.2024.1355242
- Hermanova Z, Valihrach L, Kriska J, et al. The deletion of AQP4 and TRPV4 affects astrocyte swelling/volume recovery in response to ischemia-mimicking pathologies. Front Cell Neurosci. 2024;18:1393751. doi: 10.3389/fncel.2024.1393751
- Novakovic MM, Korshunov KS, Grant RA, et al. Astrocyte reactivity and inflammation-induced depression-like behaviors are regulated by Orai1 calcium channels. Nat Commun. 2023;14(1):5500. doi: 10.1038/s41467-023-40968-6
- Ma D, Zhang H. Astrocytic aquaporin-4 expression, localization, and polarization: mechanisms and therapeutic potential in neurological diseases. Neuroscience. 2026;592:52-62. doi: 10.1016/j.neuroscience.2025.11.018
- Xing X, Zhang S. Neuroprotective Role of AQP4 Knockdown in Astrocytes After Oxygen-Glucose Deprivation. Brain Behav. 2024;14(10):e70107. doi: 10.1002/brb3.70107
- Collado J, Boland L, Ahrendsen JT, Miska J, Lee-Chang C. Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy. Front Immunol. 2024;15:1336476. doi: 10.3389/fimmu.2024.1336476
- Rubio C, Perez-Villavicencio J, Esteban-Roman NF, Lee A, Reyes-Soto G, Rubio-Osornio M. The Extracellular Matrix, the Silent ‘Architect’ of Glioma. Biomedicines. 2026;14(1):205. doi: 10.3390/biomedicines14010205
- Lee E, Chang Y. Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease. Cells. 2025;14(3):168. doi: 10.3390/cells14030168
- Vishnumukkala T, Che Mohd Nassir CMN, Hein ZM, et al. Glial Cells as Emerging Therapeutic Targets in Neurodegenerative Diseases: Mechanistic Insights and Translational Perspectives. Cells. 2025;14(19):1497. doi: 10.3390/cells14191497
- Attiq A, Afzal S, Raman H, Ahmad W. Neuroinflammation to neurodegeneration: Boulevard of broken nerves. Int Immunopharmacol. 2025;161:115015. doi: 10.1016/j.intimp.2025.115015
- Beiter RM, Sheehan PW, Schafer DP. Microglia phagocytic mechanisms: Development informing disease. Curr Opin Neurobiol. 2024;86:102877. doi: 10.1016/j.conb.2024.102877
- Haupt M, Gerner ST, Doeppner TR. The dual role of microglia in ischemic stroke and its modulation via extracellular vesicles and stem cells. Neuroprotection. 2024;2(1):4-15. doi: 10.1002/nep3.39
- Choi Y, Chung WS. Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases. Mol Neurodegener. 2025;20(1):81. doi: 10.1186/s13024-025-00870-9
- Hassan H, Rawlinson C, Lan YL, Jenkins S, Chen R. Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights. Biomolecules. 2025;15(11):1629. doi: 10.3390/biom15111629
- Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359. doi: 10.1038/s41392-023-01588-0
- Chen W, Mao T, Ma R, Xiong Y, Han R, Wang L. The role of astrocyte metabolic reprogramming in ischemic stroke (Review). Int J Mol Med. 2025;55(3):49. doi: 10.3892/ijmm.2025.5490
- Jung ES, Choi H, Mook-Jung I. Decoding microglial immunometabolism: a new frontier in Alzheimer’s disease research. Mol Neurodegener. 2025;20(1):37. doi: 10.1186/s13024-025-00825-0
- Wareham LK, Calkins DJ. Making tracks: microglia and the extracellular matrix. Mol Neurodegener. 2025;20(1):101. doi: 10.1186/s13024-025-00898-x
- Wu J, Li R, Wang J, et al. Reactive Astrocytes in Glioma: Emerging Opportunities and Challenges. Int J Mol Sci. 2025;26(7):2907. doi: 10.3390/ijms26072907
- Chang CW, Bale A, Bhargava R, Harley BAC. Glioblastoma drives protease-independent extracellular matrix invasion of microglia. Mater Today Bio. 2025;31:101475. doi: 10.1016/j.mtbio.2025.101475
- Chen J, Wu Q, Berglund AE, Macaulay RJ, Mule JJ, Etame AB. Tumor-Associated Macrophages in Glioblastoma: Mechanisms of Tumor Progression and Therapeutic Strategies. Cells. 2025;14(18):1458. doi: 10.3390/cells14181458
- Zhao W, Zhang Z, Xie M, et al. Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy. NPJ Precis Oncol. 2025;9(1):126. doi: 10.1038/s41698-025-00920-x
- Sun W, Chen P, Xu XY, Zhang JQ, Jin WL. Astrocytes in neuroinflammation and brain cancer. Mol Biomed. 2026;7(1):40. doi: 10.1186/s43556-026-00439-y
- Zheng Y, Alzoubi I, Graeber MB, et al. Consensus statement on microglial and macrophage functions in gliomas. Acta Neuropathol. 2026;151(1):39. doi: 10.1007/s00401-026-02999-3
- Zhang H, Jin Q, Li J, et al. Astrocyte-derived complement C3 facilitated microglial phagocytosis of synapses in Staphylococcus aureus-associated neurocognitive deficits. PLoS Pathog. 2025;21(4):e1013126. doi: 10.1371/journal.ppat.1013126
- Cheng YH, Ho MS. Disease-associated microglia in neurodegenerative diseases: Friend or foe? PLoS Biol. 2025;23(10):e3003426. doi: 10.1371/journal.pbio.3003426
- Sun N, Victor MB, Park YP, et al. Human microglial state dynamics in Alzheimer’s disease progression. Cell. 2023;186(20):4386-4403.e29. doi: 10.1016/j.cell.2023.08.037
- Yabo YA, Moreno-Sanchez PM, Pires-Afonso Y, et al. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. Genome Med. 2024;16(1):51. doi: 10.1186/s13073-024-01321-8
- Ardura-Fabregat A, Bosch LFP, Wogram E, et al. Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer’s disease. Nat Neurosci. 2025;28(8):1688-1703. doi: 10.1038/s41593-025-02006-0
- Berki P, Cserep C, Kornyei Z, et al. Microglia contribute to neuronal synchrony despite endogenous ATP-related phenotypic transformation in acute mouse brain slices. Nat Commun. 2024;15(1):5402. doi: 10.1038/s41467-024-49773-1
- Wu W, He Y, Chen Y, et al. In vivo imaging in mouse spinal cord reveals that microglia prevent degeneration of injured axons. Nat Commun. 2024;15(1):8837. doi: 10.1038/s41467-024-53218-0
- Rueda-Carrasco J, Sokolova D, Lee SE, et al. Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer’s disease models. EMBO J. 2023;42(19):e113246. doi: 10.15252/embj.2022113246
- Wilton DK, Mastro K, Heller MD, et al. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease. Nat Med. 2023;29(11):2866-2884. doi: 10.1038/s41591-023-02566-3
- Castellanos-Molina A, Bretheau F, Boisvert A, Belanger D, Lacroix S. Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives. Brain Behav Immun. 2024;122:583-595. doi: 10.1016/j.bbi.2024.07.047
- Shui X, Chen J, Fu Z, Zhu H, Tao H, Li Z. Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges. J Inflamm Res. 2024;17:3335-3352. doi: 10.2147/JIR.S461795
- Sadeghdoust M, Das A, Kaushik DK. Fueling neurodegeneration: metabolic insights into microglia functions. J Neuroinflammation. 2024;21(1):300. doi: 10.1186/s12974-024-03296-0
- Shokr MM. “Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders”. Metab Brain Dis. 2025;40(8):326. doi: 10.1007/s11011-025-01739-y
- Zhao Q, Li J, Feng J, et al. Cholesterol metabolic reprogramming mediates microglia-induced chronic neuroinflammation and hinders neurorestoration following stroke. Nat Metab. 2025;7(10):2099-2116. doi: 10.1038/s42255-025-01379-7
- Nejo T, Krishna S, Yamamichi A, et al. Glioma-neuronal circuit remodeling induces regional immunosuppression. Nat Commun. 2025;16(1):4770. doi: 10.1038/s41467-025-60074-z
- Bayona C, Randelovic T, Ochoa I. Tumor microenvironment in glioblastoma: The central role of the hypoxic-necrotic core. Cancer Lett. 2026;639:218216. doi: 10.1016/j.canlet.2025.218216
- Liddelow SA, Olsen ML, Sofroniew MV. Reactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders. Cold Spring Harb Perspect Biol. 2024;16(7):a041356. doi: 10.1101/cshperspect.a041356
- Serrano-Pozo A, Li H, Li Z, et al. Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease. Nat Neurosci. 2024;27(12):2384-2400. doi: 10.1038/s41593-024-01791-4
- Riboldi JG, Correa J, Renfijes MM, Tintorelli R, Viola H. Arc and BDNF mediated effects of hippocampal astrocytic glutamate uptake blockade on spatial memory stages. Commun Biol. 2024;7(1):1032. doi: 10.1038/s42003-024-06586-8
- Zhang YM, Qi YB, Gao YN, et al. Astrocyte metabolism and signaling pathways in the CNS. Front Neurosci. 2023;17:1217451. doi: 10.3389/fnins.2023.1217451
- Bataveljic D, Pivonkova H, de Concini V, et al. Astroglial Kir4.1 potassium channel deficit drives neuronal hyperexcitability and behavioral defects in Fragile X syndrome mouse model. Nat Commun. 2024;15(1):3583. doi: 10.1038/s41467-024-47681-y
- Zhang H, Zhang X, Chai Y, Wang Y, Zhang J, Chen X. Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions. Front Immunol. 2025;16:1584577. doi: 10.3389/fimmu.2025.1584577
- Kim H, Leng K, Park J, et al. Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin. Nat Commun. 2022;13(1):6581. doi: 10.1038/s41467-022-34412-4
- Huang M, Long A, Hao L, Shi Z, Zhang M. Astrocyte in Neurological Disease: Pathogenesis and Therapy. MedComm. 2025;6(8):e70299. doi: 10.1002/mco2.70299
- Pham C, Komaki Y, Deas-Just A, et al. Astrocyte aquaporin mediates a tonic water efflux maintaining brain homeostasis. eLife. 2024;13. doi: 10.7554/eLife.95873
- Rahman MS, Islam R, Bhuiyan MIH. Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases. Front Pharmacol. 2024;15:1374408. doi: 10.3389/fphar.2024.1374408
- Dong H, Wen X, Zhang BW, Wu Z, Zou W. Astrocytes in intracerebral hemorrhage: impact and therapeutic objectives. Front Mol Neurosci. 2024;17:1327472. doi: 10.3389/fnmol.2024.1327472
- Garcia Rios CA, Leon-Rojas JE. Aquaporin-4 in Stroke and Brain Edema-Friend or Foe? Int J Mol Sci. 2025;26(17):8178. doi: 10.3390/ijms26178178
- Gong Y, Wu M, Huang Y, He X, Yuan J, Dang B. Research developments in the neurovascular unit and the blood‑brain barrier (Review). Biomed Rep. 2025;22(5):1-14. doi: 10.3892/br.2025.1966
- Pfau SJ, Langen UH, Fisher TM, et al. Characteristics of blood-brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells. Nat Neurosci. 2024;27(10):1892-1903. doi: 10.1038/s41593-024-01743-y
- Sun J, He Z. Interactions between astrocytes and cerebral endothelial cells in central nervous system diseases. Biomed Pharmacother. 2025;191:118516. doi: 10.1016/j.biopha.2025.118516
- Ye Q, Jo J, Wang CY, et al. Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation. Cell Rep. 2024;43(5):114193. doi: 10.1016/j.celrep.2024.114193
- Yang Y, Tong H, Ye ZF, Xu ZC, Tao T. Research progress of neurovascular units involved in ischemic stroke. Ibrain. 2025;11(4):492-503. doi: 10.1002/ibra.12166
- Ardaya M, Tiveron MC, Cremer H, et al. Gliogenesis from the subventricular zone modulates the extracellular matrix at the glial scar after brain ischemia. eLife. 2025;13. doi: 10.7554/eLife.96076
- Koupourtidou C, Schwarz V, Aliee H, et al. Shared inflammatory glial cell signature after stab wound injury, revealed by spatial, temporal, and cell-type-specific profiling of the murine cerebral cortex. Nat Commun. 2024;15(1):2866. doi: 10.1038/s41467-024-46625-w
- O’Shea TM, Ao Y, Wang S, et al. Derivation and transcriptional reprogramming of border-forming wound repair astrocytes after spinal cord injury or stroke in mice. Nat Neurosci. 2024;27(8):1505-1521. doi: 10.1038/s41593-024-01684-6
- Lu P, Graham L, Tran AN, Villarta A, Koffler J, Tuszynski MH. A facilitatory role of astrocytes in axonal regeneration after acute and chronic spinal cord injury. Exp Neurol. 2024;379:114889. doi: 10.1016/j.expneurol.2024.114889
- Bradbury EJ, Burnside ER. Moving beyond the glial scar for spinal cord repair. Nat Commun. 2019;10(1):3879. doi: 10.1038/s41467-019-11707-7
- Yang R, Zhang Y, Kang J, Zhang C, Ning B. Chondroitin Sulfate Proteoglycans Revisited: Its Mechanism of Generation and Action for Spinal Cord Injury. Aging Dis. 2024;15(1):153-168. doi: 10.14336/AD.2023.0512
- Cui S, Guan F, Li X, Long X, Wu M. Astrocytes in glioblastoma tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2026;1881(1):189518. doi: 10.1016/j.bbcan.2025.189518
- Ghosh M, Pilanc-Kudlek P, Baluszek S, et al. Identification and characterization of tumor-associated astrocyte subpopulations and their interactions with the tumor microenvironment in experimental glioblastomas. PLoS Biol. 2025;23(10):e3002893. doi: 10.1371/journal.pbio.3002893
- Andersen BM, Faust Akl C, Wheeler MA, et al. Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions. Nature. 2025;644(8078):1097-1106. doi: 10.1038/s41586-025-09191-9
- Faust Akl C, Andersen BM, Li Z, et al. Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity. Nature. 2025;643(8070):219-229. doi: 10.1038/s41586-025-08997-x
- Malone K, Dugas M, Earl N, Alain T, LaCasse EC, Beug ST. Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds. Cell Death Dis. 2024;15(8):592. doi: 10.1038/s41419-024-06971-5
- McAlpine CS, Park J, Griciuc A, et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease. Nature. 2021;595(7869):701-706. doi: 10.1038/s41586-021-03734-6
- Chen Y, Luan P, Liu J, et al. Spatiotemporally selective astrocytic ATP dynamics encode injury information sensed by microglia following brain injury in mice. Nat Neurosci. 2024;27(8):1522-1533. doi: 10.1038/s41593-024-01680-w
- Zhang Z, Niu K, Huang T, et al. Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by alpha-synuclein overexpression. npj Parkinsons Dis. 2025;11(1):15. doi: 10.1038/s41531-024-00846-4
- Harwood DSL, Pedersen V, Bager NS, et al. Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue. Nat Commun. 2024;15(1):7857. doi: 10.1038/s41467-024-52167-y
- Jayaram MA, Phillips JJ. Role of the Microenvironment in Glioma Pathogenesis. Annu Rev Pathol. 2024;19(1):181-201. doi: 10.1146/annurev-pathmechdis-051122-110348
- Sriram S, Carstens K, Dewing W, Fiacco TA. Astrocyte regulation of extracellular space parameters across the sleep-wake cycle. Front Cell Neurosci. 2024;18:1401698. doi: 10.3389/fncel.2024.1401698
- Won W, Bhalla M, Lee JH, Lee CJ. Astrocytes as Key Regulators of Neural Signaling in Health and Disease. Annu Rev Neurosci. 2025;48(1):251-276. doi: 10.1146/annurev-neuro-112723-035356
- Ji C, Sheng L, Han K, et al. Microglial intervention in ischemic stroke: Roles and intervention strategies. Neural Regen Res. 2026;21(2):443-454. doi: 10.4103/NRR.NRR-D-24-01166
- McCallum S, Suresh KB, Islam TS, et al. Lesion-remote astrocytes govern microglia-mediated white matter repair. Nature. 2026;649(8098):959-970. doi: 10.1038/s41586-025-09887-y
- Perez-Gianmarco L, Kukley M. Understanding the Role of the Glial Scar through the Depletion of Glial Cells after Spinal Cord Injury. Cells. 2023;12(14):1842. doi: 10.3390/cells12141842
- Cieri MB, Ramos AJ. Astrocytes, reactive astrogliosis, and glial scar formation in traumatic brain injury. Neural Regen Res. 2025;20(4):973-989. doi: 10.4103/NRR.NRR-D-23-02091
- Manrique-Castano D, Bhaskar D, ElAli A. Dissecting glial scar formation by spatial point pattern and topological data analysis. Sci Rep. 2024;14(1):19035. doi: 10.1038/s41598-024-69426-z
- Muller L, Di Benedetto S. Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation. Front Cell Neurosci. 2025;19. doi: 10.3389/fncel.2025.1575022
- Sun M, Rong J, Zhou M, et al. Astrocyte-Microglia Crosstalk: A Novel Target for the Treatment of Migraine. Aging Dis. 2024;15(3):1277-1288. doi: 10.14336/AD.2023.0623
- Nomura M, Spitzer A, Johnson KC, et al. The multilayered transcriptional architecture of glioblastoma ecosystems. Nat Genet. 2025;57(5):1155-1167. doi: 10.1038/s41588-025-02167-5
- Virtuoso A, D’Amico G, Scalia F, et al. The Interplay between Glioblastoma Cells and Tumor Microenvironment: New Perspectives for Early Diagnosis and Targeted Cancer Therapy. Brain Sci. 2024;14(4):331. doi: 10.3390/brainsci14040331
- De A, Forero SA, Pirani A, et al. Single cell spatial profiling of the matrisome identifies region-specific adhesion and signaling networks in glioblastoma. Commun Biol. 2025;9(1):17. doi: 10.1038/s42003-025-09270-7
- Essakhi N, Bertucci A, Baeza-Kallee N, et al. Metabolic adaptation of myeloid cells in the glioblastoma microenvironment. Front Immunol. 2024;15. doi: 10.3389/fimmu.2024.1431112
- Planas AM. Role of microglia in stroke. Glia. 2024;72(6):1016-1053. doi: 10.1002/glia.24501
- Mathys H, Boix CA, Akay LA, et al. Single-cell multiregion dissection of Alzheimer’s disease. Nature. 2024;632(8026):858-868. doi: 10.1038/s41586-024-07606-7
- Bourne JH, Suthya AR, Wanrooy BJ, et al. Microglia are prominent producers of inflammatory cytokines during the hyperacute phase of ischemic stroke. Commun Biol. 2025;8(1):1193. doi: 10.1038/s42003-025-08636-1
- Wang Y, Ge M, Wang J, Xu Y, Wang N, Xu S. Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm. Cell Death Dis. 2025;16(1):788. doi: 10.1038/s41419-025-08114-w
- Xie L, He M, Ying C, Chu H. Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk. Front Mol Neurosci. 2024;17:1400808. doi: 10.3389/fnmol.2024.1400808
- Yu Y, Liao X, Xie X, Li Q, Chen X, Liu R. The role of neuroglial cells communication in ischemic stroke. Brain Res Bull. 2024;209:110910. doi: 10.1016/j.brainresbull.2024.110910
- Wan H, Cui Y, Zeng Y, Hu J, Li M, Xiao Z. Microglia-Astroglia-Neuron network following stroke: Novel insight into extracellular vesicles communication. Brain Res Bull. 2025;231:111537. doi: 10.1016/j.brainresbull.2025.111537
- Fan PL, Wang SS, Chu SF, Chen NH. Time-dependent dual effect of microglia in ischemic stroke. Neurochem Int. 2023;169:105584. doi: 10.1016/j.neuint.2023.105584
- Xiao L, Huang Y, Wu L, et al. The role of inflammation in Ischemic stroke: from biomarker to treatment. Front Immunol. 2025;16:1608353. doi: 10.3389/fimmu.2025.1608353
- Solomou G, Young AMH, Bulstrode H. Microglia and macrophages in glioblastoma: landscapes and treatment directions. Mol Oncol. 2024;18(12):2906-2926. doi: 10.1002/1878-0261.13657
- Yang G, Niu X, Gan J, et al. Glioblastoma exploits ATP from leading-edge astrocytes to fuel its infiltrative growth revealed by spatially resolved chimeric analysis. Sci Adv. 2025;11(39):eadv5673. doi: 10.1126/sciadv.adv5673
- Greenwald AC, Darnell NG, Hoefflin R, et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell. 2024;187(10):2485-2501.e26. doi: 10.1016/j.cell.2024.03.029
- Prakash P, Erdjument-Bromage H, O’Dea MR, et al. Proteomic profiling of interferon-responsive reactive astrocytes in rodent and human. Glia. 2024;72(3):625-642. doi: 10.1002/glia.24494
- Zucha D, Abaffy P, Kirdajova D, et al. Spatiotemporal transcriptomic map of glial cell response in a mouse model of acute brain ischemia. Proc Natl Acad Sci USA. 2024;121(46):e2404203121. doi: 10.1073/pnas.2404203121
- Rohden F, Ferreira PCL, Bellaver B, et al. Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease. Nat Commun. 2025;16(1):5653. doi: 10.1038/s41467-025-60806-1
- Ali M, Timsina J, Western D, et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. Neuron. 2025;113(9):1363-1379.e9. doi: 10.1016/j.neuron.2025.02.014
- Blujdea ER, van Bokhoven P, Martino-Adami PV, et al. Microglia protein profiles in CSF across Alzheimer’s disease clinical stages. Nat Aging. 2026;6(3):520-533. doi: 10.1038/s43587-026-01088-0
- Holper S, Loveland P, Churilov L, Italiano D, Watson R, Yassi N. Blood Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-Analysis. Neurology. 2024;103(3). doi: 10.1212/WNL.0000000000209537
- Jha RM, Rajasundaram D, Sneiderman C, et al. A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets. Neuron. 2024;112(18):3069-3088.e4. doi: 10.1016/j.neuron.2024.06.021
